Home › Celgene's Revlimid improves survival in blood cancer patients
 

Keywords :   


Celgene's Revlimid improves survival in blood cancer patients

2013-07-12 07:30:47| Biotech - Topix.net

Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in blood cancer patients.

Tags: blood cancer patients survival

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
28.09Tropical Storm Joyce Forecast Advisory Number 5
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 11
More »